Sovereign Wealth Fund, Kuwait Investment Authority Invests $250M and Joins Verizon, Celgene, Blackberry and Blackstone as Strategic Investors in NantHealth
LOS ANGELES–(BUSINESS WIRE)–October 1, 2014–
NantHealth, a NantWorks company that is combining science, data and technology to transform healthcare, announced today the closing of $250 million in additional funding from one of the world’s largest sovereign wealth funds, the Kuwait Investment Authority (KIA), to further accelerate innovation that will enable better patient care and reduced costs.
NantHealth also announced the continued expansion of its leadership team. Steve Curd has been named Chief Operating Officer, former COO of WebMD, CIO of United Healthcare and CEO of VantageMed. Additionally, Laura Beggrow, former President of Strand Diagnostics and Vice President of US Sales and Marketing at Genomics Health, has been named as Executive Vice President, Commercialization at NantHealth. Scott Holbrook, co-founder of KLAS, will join NantHealth’s Board of Directors.
“Our new leadership team has the expertise, relationships and deep knowledge necessary to drive NantHealth forward and make our vision of transforming the healthcare system and delivering truly personalized medicine a reality,” said Patrick Soon-Shiong, M.D., founder and CEO of NantHealth. “Their addition to the company along with KIA’s continued investments show the strength and confidence in NantHealth’s ability to deliver on 21st century medicine and value-based population health care.”
NantHealth combines science and technology in a single healthcare management system that enables providers to utilize big data to make real-time, evidence-based decisions. NantHealth’s robust platform of tools and solutions provides access to genomic and proteomic data at the patient level to analyze the root cause of disease, all available information about medicines and clinical trials, up-to-date scientific research, and the connectivity and data management software and infrastructure needed to make the information actionable.
“NantHealth’s goal is nothing less than transforming healthcare, knocking down the traditional barriers of today’s soiled system by enabling providers to make complex treatment decisions with all available medical information in a single location,” said Steve Curd, Chief Operating Officer. “I am tremendously excited to be a part of this visionary company during this pivotal time of structural change happening in the provision of care in our country today.”
“Providers using NantHealth solutions have the ability to analyze an individual’s unique genomic signature and collaborate and share data in real-time with all members of the patient’s healthcare team,” said Laura Beggrow, Executive Vice President, Commercialization. “This unique model has the potential to improve treatment decisions, as well as patient and financial outcomes, and that is groundbreaking.”
NantHealth’s principal leadership team now includes the following leaders in the field:
- Steve Curd, Chief Operating Officer
- Laura Beggrow, Executive Vice President, Commercialization
- Stevie Davidson, Senior Vice President, Professional Services
- Michael Davis, Senior Vice President of Corporate Strategy and Business
- Shannon Hastings, Senior Vice President, Product Engineering
- Mark Heinemeyer, Senior Vice President, Product Management
- Vasu Rangadass, Senior Vice President, Strategy and Research
- Paul Fowler, Senior Vice President, Client Services
- Siew Yong Sim-Tang, Vice President Strategic Planning
- Martin Walsh, Vice President, General Manager UK
NantHealth, a member of the NantWorks ecosystem of companies, is a transformational healthcare cloud-based IT company converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care, in the time of need, anywhere, anytime.
NantHealth works to transform clinical delivery with actionable clinical intelligence at the moment of decision, enabling clinical discovery through real-time machine learning systems. The company’s technology empowers physicians, patients, payers and researchers to transcend the traditional barriers of today’s healthcare system. By converging molecular science, near real-time patient signal monitoring, computer science and big data technology, the NantHealth Clinical Operating System (cOS) platform empowers physicians, patients, and payers to coordinate best care, monitor outcomes and control cost in real-time. This is the first system of its kind in healthcare, enabling 21st century coordinated care at a lower cost, enabling value-based population health management at a single-patient level and at the population at large. For more information please visit www.nanthealth.com and follow Dr. Soon-Shiong on Twitter @solvehealthcare.
Jen Hodson, 562-397-3639